retatrutide clinical trial results weight loss efficacy LinkInBio Tirzepatide vs. Retatrutide: Key Differences

Are there ethical concerns or considerations the industry should keep in mind when targeting GLP-1 users with specific products

Abstract Background Glucagon-like peptide-1 (GLP-1) plays a crucial role in metabolic disorders by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, thereby improving glycemic control

Senescent cells promote tissue NAD decline during ageing via the activation of CD38 macrophages

The question is whether those creatures will still be around when we finally think to ask

In this cohort study, most patients with overweight or obesity discontinued GLP-1 RA therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates, the researchers concluded